Chuanrui Ma

1.9k total citations
52 papers, 1.4k citations indexed

About

Chuanrui Ma is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Chuanrui Ma has authored 52 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 17 papers in Cancer Research and 14 papers in Surgery. Recurrent topics in Chuanrui Ma's work include Cancer, Lipids, and Metabolism (11 papers), Cholesterol and Lipid Metabolism (10 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Chuanrui Ma is often cited by papers focused on Cancer, Lipids, and Metabolism (11 papers), Cholesterol and Lipid Metabolism (10 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Chuanrui Ma collaborates with scholars based in China, United States and Malaysia. Chuanrui Ma's co-authors include Yuanli Chen, Xiaoxiao Yang, Yajun Duan, Shu Yang, Jihong Han, Lipei Liu, Yan Zhu, Xiaoju Li, Guanwei Fan and Ke Feng and has published in prestigious journals such as Chemical Communications, Scientific Reports and Chemical Engineering Journal.

In The Last Decade

Chuanrui Ma

52 papers receiving 1.4k citations

Peers

Chuanrui Ma
Hui Cai China
Kyung‐Sun Heo South Korea
Yanni Xu China
Rui Cheng United States
Jun Hao China
Ying Lu China
Mei Han China
Hui Cai China
Chuanrui Ma
Citations per year, relative to Chuanrui Ma Chuanrui Ma (= 1×) peers Hui Cai

Countries citing papers authored by Chuanrui Ma

Since Specialization
Citations

This map shows the geographic impact of Chuanrui Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanrui Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanrui Ma more than expected).

Fields of papers citing papers by Chuanrui Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuanrui Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanrui Ma. The network helps show where Chuanrui Ma may publish in the future.

Co-authorship network of co-authors of Chuanrui Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Chuanrui Ma. A scholar is included among the top collaborators of Chuanrui Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuanrui Ma. Chuanrui Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Chuanrui, Yunqing Hua, Shu Yang, et al.. (2025). Wogonin Attenuates Atherosclerosis via KLF11‐Mediated Suppression of PPARα‐YAP1‐Driven Glycolysis and Enhancement of ABCA1/G1‐Mediated Cholesterol Efflux. Advanced Science. 12(23). e2500610–e2500610. 4 indexed citations
2.
Zhang, Chao, Aifeng Liu, Shihui Li, et al.. (2024). A supramolecular formulation of icariin@sulfonatoazocalixarene for hypoxia-targeted osteoarthritis therapy. Chinese Chemical Letters. 36(1). 109752–109752. 4 indexed citations
3.
Yang, Shu, Shangjing Liu, Yifan Wu, et al.. (2024). The plant extract PNS mitigates atherosclerosis via promoting Nrf2‐mediated inhibition of ferroptosis through reducing USP2‐mediated Keap1 deubiquitination. British Journal of Pharmacology. 181(23). 4822–4844. 8 indexed citations
4.
Wang, Shengnan, Mengmeng Zhu, Hui Ma, et al.. (2024). Colchicine reduces neointima formation and VSMC phenotype transition by modulating SRF-MYOCD activation and autophagy. Acta Pharmacologica Sinica. 46(4). 951–963. 3 indexed citations
5.
Li, Sheng, Ke Yang, Rui Guo, et al.. (2023). Tanshinone IIA enhances the therapeutic efficacy of mesenchymal stem cells derived exosomes in myocardial ischemia/reperfusion injury via up-regulating miR-223-5p. Journal of Controlled Release. 358. 13–26. 52 indexed citations
6.
Yang, Shu, Jiaqing Xiang, Chuanrui Ma, et al.. (2023). Sp1-like protein KLF13 acts as a negative feedback regulator of TGF-β signaling and fibrosis. Cell Reports. 42(4). 112367–112367. 9 indexed citations
7.
Wei, Xiaoning, Mengmeng Zhu, Mengyuan Fang, et al.. (2023). The pterostilbene-dihydropyrazole derivative Ptd-1 ameliorates vascular calcification by regulating inflammation. International Immunopharmacology. 125(Pt B). 111198–111198. 6 indexed citations
9.
Liu, Zhihao, Xiaozhi Liu, Li Liu, et al.. (2022). SUMO1 regulates post-infarct cardiac repair based on cellular heterogeneity. Journal of Pharmaceutical Analysis. 13(2). 170–186. 3 indexed citations
10.
Ni, Jingyu, Hao Zhang, Xiaodan Wang, et al.. (2022). Rg3 regulates myocardial pyruvate metabolism via P300-mediated dihydrolipoamide dehydrogenase 2-hydroxyisobutyrylation in TAC-induced cardiac hypertrophy. Cell Death and Disease. 13(12). 1073–1073. 20 indexed citations
11.
Ma, Chuanrui, Xinyu Wang, Jing Zhang, et al.. (2022). Exploring Ganweikang Tablet as a Candidate Drug for NAFLD Through Network Pharmacology Analysis and Experimental Validation. Frontiers in Pharmacology. 13. 893336–893336. 4 indexed citations
12.
Hua, Yunqing, Jing Zhang, Qianqian Liu, et al.. (2022). The Induction of Endothelial Autophagy and Its Role in the Development of Atherosclerosis. Frontiers in Cardiovascular Medicine. 9. 831847–831847. 26 indexed citations
13.
Ma, Chuanrui, Ke Feng, Xiaoxiao Yang, et al.. (2021). Targeting macrophage liver X receptors by hydrogel‐encapsulated T0901317 reduces atherosclerosis without effect on hepatic lipogenesis. British Journal of Pharmacology. 178(7). 1620–1638. 21 indexed citations
14.
Zou, Yang, Lan Li, Yuan Li, et al.. (2021). Restoring Cardiac Functions after Myocardial Infarction–Ischemia/Reperfusion via an Exosome Anchoring Conductive Hydrogel. ACS Applied Materials & Interfaces. 13(48). 56892–56908. 108 indexed citations
15.
Ma, Chuanrui, Han Wu, Guangyan Yang, et al.. (2021). Calycosin ameliorates atherosclerosis by enhancing autophagy via regulating the interaction between KLF2 and MLKL in apolipoprotein E gene‐deleted mice. British Journal of Pharmacology. 179(2). 252–269. 32 indexed citations
16.
Ma, Chuanrui, Jiaqing Xiang, Guixiao Huang, et al.. (2021). Pterostilbene Alleviates Cholestasis by Promoting SIRT1 Activity in Hepatocytes and Macrophages. Frontiers in Pharmacology. 12. 785403–785403. 12 indexed citations
17.
Zhang, Juntao, Chao Zhang, Aifeng Liu, et al.. (2021). Synthesis of Icariin-Zinc and its Protective Effect on Exercise Fatigue and Reproductive System Related Glands in Male Rats. Frontiers in Pharmacology. 12. 611722–611722. 9 indexed citations
18.
Zeng, Peng, Jie Yang, Lipei Liu, et al.. (2020). ERK1/2 inhibition reduces vascular calcification by activating miR-126-3p-DKK1/LRP6 pathway. Theranostics. 11(3). 1129–1146. 50 indexed citations
19.
Yang, Shu, Lingling Wei, Lipei Liu, et al.. (2019). Formononetin ameliorates cholestasis by regulating hepatic SIRT1 and PPARα. Biochemical and Biophysical Research Communications. 512(4). 770–778. 41 indexed citations
20.
Liu, Ying, Wei Zhuo, Ye Zhang, et al.. (2018). Activation of liver X receptor plays a central role in antiviral actions of 25-hydroxycholesterol. Journal of Lipid Research. 59(12). 2287–2296. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026